CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Recent Updates on Glucagon-Like Peptide 1 Receptor Agonist
Hae Jin Kim
J Korean Diabetes. 2021;22(2):126-133.   Published online June 30, 2021

Excel Download

Recent Updates on Glucagon-Like Peptide 1 Receptor Agonist
The Journal of Korean Diabetes. 2021;22(2):126-133   Crossref logo
Link1 Link2 Link3

Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects
Journal of Diabetes Investigation. 2020;11(6):1448-1456   Crossref logo
Link1 Link2 Link3 Link4

Which to choose, an oral or an injectable glucagon-like peptide-1 receptor agonist?
The Lancet. 2019;394(10192):4-6   Crossref logo
Link1 Link2

Anaphylactic Reaction to Dulaglutide: A Glucagon Like Peptide- 1 Receptor Agonist
Journal of the Endocrine Society. 2021;5(Supplement_1):A367-A368   Crossref logo
Link1 Link2

Semaglutide: a promising new glucagon-like peptide-1 receptor agonist
The Lancet Diabetes & Endocrinology. 2017;5(4):236-238   Crossref logo
Link1 Link2

ALX-0600: A potent glucagon-like peptide-2 receptor agonist
Gastroenterology. 2001;120(5):A509-A509   Crossref logo
Link1 Link2

Injectable Therapy for Diabetes Mellitus: Glucagon-Like Peptide-1 Receptor Agonist
The Journal of Korean Diabetes. 2019;20(3):149   Crossref logo
Link1 Link2 Link3

The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling
Bioscience Reports. 2016;36(1):   Crossref logo
Link1 Link2

Oral Semaglutide: The First-available Noninjectable Glucagon-like Peptide 1 Receptor Agonist
Clinical Therapeutics. 2020;42(10):2100-2116   Crossref logo
Link1 Link2

A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2015;363   Crossref logo